James M Daly insider trades

Open-market stock purchases and sales by James M Daly, Director at Cytokinetics Inc, from SEC Form 4 filings since Oct 22, 2012.

Recent trades

DateStockTradeValue
Jul 15, 2026CYTK Cytokinetics IncBought (not open market)$12.5K
Jun 17, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
Jun 17, 2026MDGL Madrigal Pharmaceuticals, IncBought (not open market)—
May 29, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
May 29, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
May 29, 2026ACAD Acadia Pharmaceuticals IncBought (not open market)—
May 27, 2026CYTK Cytokinetics IncBought (not open market)—
May 27, 2026CYTK Cytokinetics IncBought (not open market)—
Apr 15, 2026CYTK Cytokinetics IncBought (not open market)$12.5K
Jan 15, 2026CYTK Cytokinetics IncBought (not open market)$12.5K
Nov 10, 2025ACAD Acadia Pharmaceuticals IncSold$671K

Companies traded

  • CYTK Cytokinetics Inc: other filings, last Jul 15, 2026
  • MDGL Madrigal Pharmaceuticals, Inc: 19 sales, last Jun 17, 2026
  • ACAD Acadia Pharmaceuticals Inc: 4 sales, last May 29, 2026
  • HALO Halozyme Therapeutics, Inc: 4 sales, last Aug 14, 2023
  • BLCM Bellicum Pharmaceuticals, Inc: other filings, last Jan 3, 2023
  • CMRX Chimerix Inc: other filings, last Jun 20, 2019
  • INCY Incyte Corp: 20 sales, last Jun 23, 2015

Get free alerts when James M Daly files a new trade →